Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation

Emily C. MacDuffie, Luis Cocka, Xiang Lin, Memory Bvochora-Nsingo, Sebathu Chiyapo, Dawn Balang, Bokang Maswabi, Kebatshabile Ngoni, Doreen Ramogola-Masire, Nicola M. Zetola, Zhi Wei, Hao Shen, Sheynaz Bassa, Surbhi Grover, Erle S. Robertson

Research output: Contribution to journalArticlepeer-review

Abstract

SIGNIFICANCE: Chemoradiation affects the immune system of patients with cervical cancer with well-controlled HIV infection differently than those without HIV, yet their survival does not differ. This finding is an important step in understanding how management of HIV infection can modify cancer outcomes, particularly in settings with a high burden of HIV.

Original languageEnglish (US)
Pages (from-to)610-620
Number of pages11
JournalCancer Research Communications
Volume5
Issue number4
DOIs
StatePublished - Apr 1 2025
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • General Medicine

Fingerprint

Dive into the research topics of 'Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation'. Together they form a unique fingerprint.

Cite this